Bota Bio

Let Biotechnology Illuminate Daily Lives

Hangzhou, China · Founded 2019 · $115.0M raised

Headquarters
Hangzhou
Employees
51–200
Founded
2019
Business Model
B2B
Website
bota.bio
Total Funding
$115.0M
Last Round
$100.0M Series BJul 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Bota Bio (Bota Biosciences, 恩和科技) is an industrial synthetic biotechnology company founded in 2019 and headquartered in Hangzhou, China with a US office in Lafayette, California. The company operates a proprietary Biofoundry platform combining computer algorithms and state-of-the-art biotechnologies to develop sustainable bio-manufacturing solutions. Products include bio-preservatives, nutritional supplements, performance proteins, and personal care ingredients under brands HeliaGenesis and YuccaElements. Bota Bio raised $100 million in Series B financing in 2021, with total funding of $145 million. BASF Venture Capital is among its investors. The company has a 130,000 m² fermentation production plant with over 600 tons annual capacity.

Summary

Bota Bio is a Biotech company based in Hangzhou, China, founded in 2019. It has raised $115.0M in total across 2 rounds, most recently a $100.0M Series B round in Jul 2021. Investors include Source Code Capital, Sequoia Capital and Matrix Partners China.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJul 2021
$100.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bota Bio on Indexed.vc
<a href="https://indexed.vc/companies/bota-bio"><img src="https://indexed.vc/api/badge/company/bota-bio" alt="Bota Bio on Indexed.vc" width="260" height="76" /></a>